Abstract
Background It is unknown why a minority of women fail to clear human papillomavirus (HPV) and develop precancer/cancer. Differences in T-cell receptor (TCR) repertoires may identify HPV16-infected women at highest-risk for progression to cancer. We conducted a proof-of-principle study nested within the Guanacaste HPV Natural History Study to evaluate the utility of next-generation sequencing for interrogating the TCR repertoires among women who cleared and failed to clear cervical HPV16. Methods TCR repertoires of women with HPV16-related intraepithelial neoplasia grade 3 or higher (CIN3+; n = 25) were compared to women who cleared an incident HPV16 infection without developing precancer/cancer (n = 25). TCR diversity (richness and evenness) and relative abundance (RA) of gene segment (V [n = 51], D [n = 2], J [n = 13]) usage was evaluated; receiver operating curve analysis assessed the ability to differentiate case-control status. Results TCR repertoire richness was associated with CIN3+ status (P = 0.001). Relative abundance (RA) of V-gene segments was enriched for associations between cases and controls. A single V-gene (TRBV6-7) was significantly associated with CIN3+ status (RA = 0.11%, 0.16%, among cases and controls, respectively, Bonferroni P = 0.0008). The estimated area under the curve using richness and V-gene segment RA was 0.83 (95% confidence interval: 0.73–0.90). Conclusions Substantial differences in TCR repertoire among women with CIN3+ compared to women who cleared infection were observed.
| Original language | English |
|---|---|
| Article number | e0178167 |
| Journal | PLoS ONE |
| Volume | 13 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2018 |
Bibliographical note
Publisher Copyright:© This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding
This work was supported by the intramural research program at the National Cancer Institute, Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch (Mahboobeh Safaeian). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. David Hamm and Harlan Robins have employment and stock options at Adaptive Biotechnologies. Adaptive Biotechnologies provided support in the form of salaries for authors [DH, HR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section. These data were presented in abstract form at the American Society of Preventive Oncology Annual Meeting, Birmingham Alabama (2015).
| Funders | Funder number |
|---|---|
| National Childhood Cancer Registry – National Cancer Institute | U01CA078527 |
| National Childhood Cancer Registry – National Cancer Institute | |
| American Society of Preventive Oncology | |
| Center for Genomic Epidemiology |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- General
Fingerprint
Dive into the research topics of 'T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver